Postoperative Hypoventilation After Intrathecal Morphine and PCA in OSA
A 58-year-old man (BMI 38, STOP-BANG 6, treated OSA on CPAP) has an elective total knee arthroplasty under spinal anesthesia with 12.5 mg bupivacaine and 300 mcg intrathecal morphine, plus a hydromorphone PCA started in PACU. Forty minutes after arrival he is drowsy but rousable (POSS 3), with a respiratory rate of 6/min, SpO2 88% on 4 L nasal prongs, and nasal-capnography EtCO2 of 59 mmHg. HR is 62 and BP is 98/54 mmHg. Train-of-four shows four twitches with a ratio of 0.62. He received 1 mg midazolam and 4 mg hydromorphone in the past hour. He used CPAP at home but did not bring it, and his wife says he "stops breathing" at night without it.
1. Stratify the causes of his hypoventilation and explain how you would address each.
Read the worked answer
Causes, in order of likely contribution:
- Opioids: 300 mcg intrathecal morphine has a delayed rostral spread peaking 6–12 hours, and PCA hydromorphone (4 mg in an hour) is additive. Address by stopping the PCA and titrating naloxone if needed.
- Residual neuromuscular blockade: TOF ratio 0.62 is inadequate (target ≥0.9) and causes hypoventilation and airway obstruction. Address with sugammadex.
- OSA plus supine position without CPAP: upper airway collapsibility and blunted arousal. Address with head-up positioning, airway maneuvers, and CPAP/BiPAP.
- Benzodiazepine: 1 mg midazolam adds sedation and synergizes with opioids; no further sedatives.
Immediate actions: stimulate the patient, open the airway, apply CPAP or BiPAP, place on continuous capnography and pulse oximetry, check a blood glucose and temperature, and call for help. Reassess after each intervention rather than stacking treatments, so you know what worked. The combination of sedation score 3, RR 6, and EtCO2 59 mmHg is impending respiratory failure and warrants immediate escalation.
2. Would you give naloxone, sugammadex, or both? Justify the dose and sequence, and the risks of each.
Read the worked answer
Both, in a deliberate order.
- Sugammadex 2 mg/kg first (TOF ratio 0.62 reflects moderate block; 4 mg/kg is for deep block). This addresses a reversible contributor without touching analgesia, and its effect is complete in minutes.
- Then naloxone 40–80 mcg IV boluses, repeated every 2–3 minutes, titrated to a respiratory rate >10/min and adequate EtCO2 rather than to full wakefulness. Intrathecal morphine will outlast naloxone (naloxone duration 30–60 minutes), so the patient must be monitored for re-narcotization and may need an infusion.
Risks:
- Naloxone: sudden severe pain, catecholamine surge, hypertension, tachycardia, pulmonary edema, and re-sedation after the bolus wears off.
- Sugammadex: bradycardia, rare anaphylaxis, and interaction with hormonal contraception.
If hypoventilation persists after sugammadex and 80–120 mcg naloxone, the correct move is to intubate rather than to keep pushing reversal agents. Continue CPAP in the meantime.
3. What is your disposition and monitoring plan, and how would you prevent this in the same patient next time?
Read the worked answer
Disposition: ICU or a high-acuity step-down unit with continuous pulse oximetry and capnography, an available CPAP/BiPAP machine, and a documented plan for opioid and naloxone administration. Observe at least 24 hours after the last naloxone dose because intrathecal morphine's effect is prolonged. Stop the PCA and switch to multimodal analgesia; a rescue opioid should be prescribed at low dose with monitoring.
Prevention next time:
- Reduce or omit intrathecal morphine (e.g., 100–150 mcg) or avoid combining it with a PCA.
- Place an adductor canal block for knee analgesia to spare opioids.
- Bring the patient's own CPAP or start auto-CPAP early in the PACU; avoid supine positioning.
- Avoid benzodiazepines and other sedatives in OSA patients.
- Use objective neuromuscular monitoring and extubate only at TOF ratio ≥0.9.
- Consider extended monitoring (≥24 hours) for known OSA plus neuraxial opioid; a POSS score and continuous capnography are more reliable than intermittent respiratory rate checks.